SCHEMBL1846424

SCHEMBL1846424

CCNC(=O)Nc1nc2c(F)c(-c3ccc(N4CCN(C)CC4)nc3)cc(-c3ccccn3)c2s1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACVR1B P36896 1/20 0.44
▸ TGFBR1 P36897 1/20 0.44
▸ TRPV4 Q9HBA0 1/20 0.41
▸ DYRK1A Q13627 2/20 0.39
▸ CNR2 P34972 1/20 0.39
▸ ACHE P22303 1/20 0.38
▸ P2RX7 Q99572 1/20 0.38
▸ KIT P10721 1/20 0.38
▸ KDR P35968 1/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ BACE1 P56817 1/20 0.38
▸ BACE2 Q9Y5Z0 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ WNT1 P04628 1/20 0.38
▸ CLK2 P49760 1/20 0.38
▸ CLK3 P49761 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1844044 0.92 HDAC2 (0.45) ACVR1BTGFBR1CNR2FLT3HDAC1
SCHEMBL1846451 0.92 PIK3CA (0.45) CNR2ABL1
SCHEMBL4544055 0.91 LMNA (0.40) ACVR1BTGFBR1CNR2ACHEP2RX7
SCHEMBL1845355 0.91 TRPV4 (0.41) ACVR1BTGFBR1TRPV4DYRK1AACHE
Hydrochloric Acid SCHEMBL4542422 0.90 LMNA (0.40) ACVR1BTGFBR1CNR2ACHEP2RX7
SCHEMBL1840483 0.90 ABL1 (0.37) CNR2ABL1
Hydrochloric Acid SCHEMBL1841930 0.89 ABL1 (0.36) CNR2ABL1
Hydrochloric Acid SCHEMBL1843751 0.88 ACHE (0.43) ACVR1BTGFBR1ACHEP2RX7KIT
SCHEMBL1845261 0.86 RIPK1 (0.42) TRPV4DYRK1AABL1
SCHEMBL1840222 0.86 FLT3 (0.41) DYRK1AKITKDRFLT3ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166088-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2011-07-07 — — US claimed
US-20110166088-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2011-07-07 — — US disclosed
EP-2321309-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS Ranbaxy Laboratories Limited (IN) 2011-05-18 — — EP disclosed
WO-2009156966-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2009-12-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166088-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS TOP2B, TOP1, POLI ACVR1B 4206/4885TGFBR1 3737/4885TRPV4 2849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback